LONDON, May 12 (Reuters) - Private equity firm Clayton,
Dubilier & Rice (CDR) has agreed to buy London-listed UDG
Healthcare for 2.6 billion pounds ($3.7 billion), the
pharmaceuticals services company said on Wednesday.
CDR has agreed to pay 10.23 pounds in cash per share in UDG,
a premium of 21.5% on Tuesday's close.
($1 = 0.7076 pounds)
(Editing by Keith Weir and Jason Neely)